Inhibition of Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells

被引:0
|
作者
Zhu, Ningxi [1 ]
Gu, Lubing [1 ]
Zhou, Muxiang [1 ]
机构
[1] Emory Univ, Atlanta, GA 30322 USA
关键词
D O I
10.1182/blood.V110.11.2790.2790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2790
引用
收藏
页码:821A / 821A
页数:1
相关论文
共 50 条
  • [1] Inhibition of the Akt/survivin pathway synergizes the antileukernia effect of nutlin-3 in acute lymphoblastic leukemia cells
    Zhu, Ningxi
    Gu, Lubing
    Li, Fengzhi
    Zhou, Muxiang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (05) : 1101 - 1109
  • [2] Vemurafenib Synergizes with Nutlin-3 to Deplete Survivin and Suppresses Melanoma Viability and Tumor Growth
    Ji, Zhenyu
    Kumar, Raj
    Taylor, Michael
    Rajadurai, Anpuchchelvi
    Marzuka-Alcala, Alexander
    Chen, Y. Erin
    Njauw, Ching-Ni Jenny
    Flaherty, Keith
    Jonsson, Goran
    Tsao, Hensin
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4383 - 4391
  • [3] Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells
    Tisato, Veronica
    Norcio, Alessia
    Celeghini, Claudio
    Milani, Daniela
    Gonelli, Arianna
    Secchiero, Paola
    [J]. CLINICS, 2014, 69 (01) : 68 - 74
  • [4] Akt/survivin pathway inhibition synergizes the apoptotic cell death induced by A-santalol in prostate cancer cells
    Bommareddy, Ajay
    Lockus, Lauren
    Seward, Jonathan
    Eggelston, William
    Prelewicz, Stacy
    Antal, Andrea
    Fillman, Sarah
    Castro, Christian
    VanWert, Adam L.
    Santha, Sreevidya
    Dwivedi, Chandradhar
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [5] Oridonin synergizes with Nutlin-3 in osteosarcoma cells by modulating the levels of multiple Bcl-2 family proteins
    Wang, Xiao-Hui
    Zhang, Shu-Feng
    Bao, Jun-Tao
    Liu, Fu-Yun
    [J]. TUMOR BIOLOGY, 2017, 39 (06)
  • [6] Analysis of the PI3/Akt/Survivin Pathway in Acute Myelogenous Leukemia.
    Serrano, Josefina
    Serrano-Lopez, Juana
    Sanchez Garcia, Joaquin
    Herrera, Concepcion
    Torres Gomez, Antonio P.
    [J]. BLOOD, 2009, 114 (22) : 1037 - 1038
  • [7] Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers
    Ohgami, Tatsuhiro
    Kato, Kiyoko
    Kobayashi, Hiroaki
    Sonoda, Kenzo
    Inoue, Takafumi
    Yamaguchi, Shin-ichiro
    Yoneda, Tomoko
    Wake, Norio
    [J]. CANCER SCIENCE, 2010, 101 (06): : 1387 - 1395
  • [8] Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells
    Secchiero, Paola
    Zerbinati, Carlotta
    di Iasio, Maria Grazia
    Melloni, Elisabetta
    Tiribelli, Mario
    Grill, Vittorio
    Zauli, Giorgio
    [J]. CURRENT DRUG METABOLISM, 2007, 8 (04) : 395 - 403
  • [9] Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia
    Jiang, Xuejie
    Mak, Po Yee
    Mu, Hong
    Tao, Wenjing
    Mak, Duncan H.
    Kornblau, Steven
    Zhang, Qi
    Ruvolo, Peter
    Burks, Jared K.
    Zhang, Weiguo
    McQueen, Teresa
    Pan, Rongqing
    Zhou, Hongsheng
    Konopleva, Marina
    Cortes, Jorge
    Liu, Qifa
    Andreeff, Michael
    Carter, Bing Z.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (10) : 2417 - 2429
  • [10] SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
    Juan C. García-Cañaveras
    Olga Lancho
    Gregory S. Ducker
    Jonathan M. Ghergurovich
    Xincheng Xu
    Victoria da Silva-Diz
    Sonia Minuzzo
    Stefano Indraccolo
    Hahn Kim
    Daniel Herranz
    Joshua D. Rabinowitz
    [J]. Leukemia, 2021, 35 : 377 - 388